Risk factor
Very poor trading liquidity
Profitability factor
Undervalued vs peers
About
Novolog (Pharm-Up 1966) Ltd, operating from its headquarters in Modi'in-Maccabim-Re'ut, Israel, offers a comprehensive suite of healthcare solutions. The company is involved in distributing critical medical equipment to both clinical establishments and individuals receiving care at home. It also provides essential medical logistics support for businesses within the pharmaceutical and medical device sectors. Beyond direct provisions, Novolog develops bespoke treatment plans and arranges for nurses to conduct home visits. It plays a role in public and professional health education by generating and circulating valuable medical information and practical resources. Furthermore, the firm extends its expertise to corporate clients, offering management services for their health and medical processes. Novolog also specializes in the sterilization of medical and laboratory items using ethylene oxide gas and facilitates direct engagement with the health and wellness ecosystem for international enterprises.
Company Valuation
Based on key historical and expected multiples, the stock is undervalued relative to its peers. Specifically, the stock is 'expensive' on P/E, undervalued on EV/EBITDA, u